Excelerate Health Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
S2N Health provides commercial intelligence, analytics, and go-to-market strategy services for medtech, diagnostics, digital health, and drug delivery companies, from startups to global enterprises.
AI & Machine LearningHealthtechMedical DevicesSales TechBoston, US
Amy Siegel(CEO & Co-Founder)inTim Kofol(CTO & Co-Founder)inTimothy Kofol(Executive Officer, Director)Leah Shea(Chief Product Officer)in
BoardRoome Hugh(Director)Andrew Schwab(Director)in
Co-investorsRittenhouse VenturesRobin Hood VenturesBoston Millennia Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.